The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) ROE % Adjusted to Book Value: 0.00% (As of . 20)


DHA:IBNSINA The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
20 GF Score
Price BDT317.30
View Full Analysis

What is The IBN SINA Pharmaceutical Industry ROE % Adjusted to Book Value?

The IBN SINA Pharmaceutical Industry DHA:IBNSINA -0.72% 20 ROE % Adjusted to Book Value is 0.00% as of . 20. GuruFocus rates DHA:IBNSINA with a GF Score™ of 20/100.

The IBN SINA Pharmaceutical Industry's ROE % for the quarter that ended in . 20 was 0.00%. The IBN SINA Pharmaceutical Industry's PB Ratio for the quarter that ended in . 20 was N/A. The IBN SINA Pharmaceutical Industry's ROE % Adjusted to Book Value for the quarter that ended in . 20 was N/A.

The IBN SINA Pharmaceutical Industry ROE % Adjusted to Book Value Related Terms

The IBN SINA Pharmaceutical Industry ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for The IBN SINA Pharmaceutical Industry's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The IBN SINA Pharmaceutical Industry ROE % Adjusted to Book Value Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
ROE % Adjusted to Book Value

The IBN SINA Pharmaceutical Industry Semi-Annual Data
ROE % Adjusted to Book Value

DHA:IBNSINA vs IMNPQ: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, The IBN SINA Pharmaceutical Industry's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The IBN SINA Pharmaceutical Industry ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The IBN SINA Pharmaceutical Industry's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where The IBN SINA Pharmaceutical Industry's ROE % Adjusted to Book Value falls into.


DHA:IBNSINA
20GF Score
The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The IBN SINA Pharmaceutical Industry ROE % Adjusted to Book Value Calculation

The IBN SINA Pharmaceutical Industry's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

The IBN SINA Pharmaceutical Industry's ROE % Adjusted to Book Value for the quarter that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a ROE % Adjusted to Book Value of 0.00% as of . 20. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on The IBN SINA Pharmaceutical Industry and its competitors.
Is The IBN SINA Pharmaceutical Industry's ROE % Adjusted to Book Value too high?
The IBN SINA Pharmaceutical Industry's current ROE % Adjusted to Book Value is 0.00%. Overall, The IBN SINA Pharmaceutical Industry has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does The IBN SINA Pharmaceutical Industry's ROE % Adjusted to Book Value compare to IMNPQ?
The IBN SINA Pharmaceutical Industry's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. The IBN SINA Pharmaceutical Industry's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The IBN SINA Pharmaceutical Industry stock overvalued right now?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. The IBN SINA Pharmaceutical Industry's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For The IBN SINA Pharmaceutical Industry (DHA:IBNSINA), the current ROE % Adjusted to Book Value is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The IBN SINA Pharmaceutical Industry Business Description

Address Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
20GF Score

Get the complete analysis for DHA:IBNSINA

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT317.30
Price